INDEMNIFICATION AGREEMENTIndemnification Agreement • March 31st, 2014 • Capricor Therapeutics, Inc. • Pharmaceutical preparations • Delaware
This Indemnification Agreement, dated as of ________, 2014 is made by and between CAPRICOR THERAPEUTICS, INC., a Delaware corporation (the “Company”), and ______________, a director, officer or key employee of the Company or one of the Company’s subsidiaries or Affiliates or other service provider who satisfies the definition of Indemnifiable Person set forth below (“Indemnitee”).
AMENDED AND RESTATED EXCLUSIVE LICENSE AGREEMENTExclusive License Agreement • March 31st, 2014 • Capricor Therapeutics, Inc. • Pharmaceutical preparations • California
This Amended and Restated Exclusive License Agreement (“Restated Agreement”) is entered into and effective this 30th day of December, 2013 (“Amended Effective Date”) by and between Cedars-Sinai Medical Center, a California nonprofit public benefit corporation (“CSMC”), with offices at 8700 Beverly Boulevard, Los Angeles, California 90048-1865, and Capricor, Inc., a Delaware corporation (“Licensee”), with offices at 8840 Wilshire Blvd., 2nd Floor, Beverly Hills, California 90211.
LEASE AGREEMENTLease Agreement • March 31st, 2014 • Capricor Therapeutics, Inc. • Pharmaceutical preparations • California
THIS LEASE ("Lease") is made on March 29, 2012 between The Bubble Real Estate Company, LLC. a California limited liability company, (hereinafter referred to as "Lessor") and Capricor, Inc., a Delaware Incorporation located at 8700 Beverly Blvd, Davis Building Rm. # 1099 Los Angeles, CA 90048 (hereinafter referred to as "Lessee").
FACILITIES LEASE between CEDARS-SINAI MEDICAL CENTER, a California nonprofit corporation and Capricor Inc. a Delaware corporation FACILITIES LEASEFacilities Lease • March 31st, 2014 • Capricor Therapeutics, Inc. • Pharmaceutical preparations • California
THIS FACILITIES LEASE ("Lease") is made and entered into as of January 1st, 2008, by and between CEDARS-SINAI MEDICAL CENTER, a California nonprofit public benefit corporation ("Landlord"), and CAPRICOR INC., a Delaware corporation ("Tenant"), with reference to the following facts and circumstances:
SUBLEASESublease • March 31st, 2014 • Capricor Therapeutics, Inc. • Pharmaceutical preparations • California
This Sublease ("Sublease") is made and shall be effective as of the 1st day of May, 2012, by and between CAPRICOR, INC., a Delaware corporation whose principal office is located at 8840 Wilshire Blvd., 3rd Floor, Beverly Hills, California 90211 ("Sublessor"), and FRANK LITVACK, an individual whose address is 8550 Wilshire Blvd., Ste. 840, Los Angeles, California 90010 ("Sublessee").
CONSULTING AGREEMENTConsulting Agreement • March 31st, 2014 • Capricor Therapeutics, Inc. • Pharmaceutical preparations • California
THIS CONSULTING AGREEMENT (“Agreement”) is made and shall be effective as of the 24th day of March, 2014 (the “Effective Date”), by and between Capricor, Inc., a Delaware corporation with its offices at 8840 Wilshire Blvd., 2nd Floor, Beverly Hills, California 90211 (“Capricor”) and Frank Litvack, MD, whose address is c/o 8550 Wilshire Blvd., Ste. 840, Los Angeles, California 90010 (“Consultant”).
SECOND AMENDMENT TO LICENSE AGREEMENTLicense Agreement • March 31st, 2014 • Capricor Therapeutics, Inc. • Pharmaceutical preparations
This Second Amendment to the License Agreement and first amendment (JHU Agreement (JHTT # A02186 and A16248 dated 22-June-2006 and 05-May-2009, collectively, the “Agreement”), is entered into as of 20 December 2013 by and among CAPRICOR, INC, a Delaware corporation having an address at 8840 Wilshire Blvd, 2nd Floor, Beverly Hills, CA 90211 (“Company”), and Johns Hopkins University (“JHU”), having offices at 3400 N. Charles Street, Baltimore, MD 21218-2695.
FIRST AMENDMENT TO LEASELease Agreement • March 31st, 2014 • Capricor Therapeutics, Inc. • Pharmaceutical preparations
This First Amendment to Lease (this “Amendment”) is dated as of June 13, 2013, and is made by and between The Bubble Real Estate Company, LLC, a California limited liability company (“Lessor”) and Capricor, Inc., a Delaware corporation (“Lessee”), with reference to the following facts and circumstances:
AGREEMENT TO AMEND EXCLUSIVE LICENSE AGREEMENTExclusive License Agreement • March 31st, 2014 • Capricor Therapeutics, Inc. • Pharmaceutical preparations
This Agreement to amend ("the Amendment") the Exclusive License Agreement JHTT#A02186 dated June 22, 2006 ("the Agreement") is between Capricor, a Delaware corporation located at 8700 Beverly Blvd., Davis Building, Room D-1063, Los Angeles, CA 90048 ("the Company") and Johns Hopkins University, a Maryland corporation located at 3400 N. Charles Street Baltimore, MD 21218-2695 ("JHU") (collectively "the Parties").
COLLABORATION AGREEMENT AND LICENSE OPTIONCollaboration Agreement and License Option • March 31st, 2014 • Capricor Therapeutics, Inc. • Pharmaceutical preparations • Delaware
This Collaboration Agreement and License Option (this “Agreement”), dated as of December 27, 2013 (the “Effective Date”), is made by and between Capricor, Inc., a Delaware corporation, having its principal place of business at 8840 Wilshire Boulevard, 2nd Floor, Beverly Hills, California 90211 (“Capricor”), and Janssen Biotech, Inc., a Pennsylvania corporation, and having an office at 800/850 Ridgeview Drive, Horsham, Pennsylvania 19044 (“JBI”). Capricor and JBI are sometimes referred to herein individually as a “Party” and collectively as the “Parties.”
CALIFORNIA INSTITUTE FOR REGENERATIVE MEDICINE LOAN AGREEMENTLoan Agreement • March 31st, 2014 • Capricor Therapeutics, Inc. • Pharmaceutical preparations • California
This LOAN AGREEMENT (the “Agreement”) is entered into as of the Effective Date (as defined below), by and between the California Institute for Regenerative Medicine (“CIRM”) and Capricor, Inc. (“Loan Recipient”).
LICENSE AGREEMENTLicense Agreement • March 31st, 2014 • Capricor Therapeutics, Inc. • Pharmaceutical preparations
EMPLOYMENT AGREEMENTEmployment Agreement • March 31st, 2014 • Capricor Therapeutics, Inc. • Pharmaceutical preparations • Delaware
2010, by and between CAPRICOR, INC., a Delaware corporation, with its principal place of business presently in California (hereinafter referred to as "Capricor"), and LINDA S. MARBAN, PH.D., a California resident (hereinafter referred to as "Dr. Marban"),
EMPLOYMENT AGREEMENTEmployment Agreement • March 31st, 2014 • Capricor Therapeutics, Inc. • Pharmaceutical preparations • Delaware
THIS EMPLOYMENT AGREEMENT (“Agreement”) is made and shall be effective as of February 18, 2013 (the “Effective Date”), by and between Capricor, Inc., a Delaware corporation, whose offices are located at 8840 Wilshire Blvd., 3rd Floor, Beverly Hills, California 90211 (the “Company”), and Dr. Anthony H. Davies (“Employee”) who resides at 15945 Niles Road, Los Gatos, California 95033.
EXCLUSIVE LICENSE AGREEMENT BETWEEN THE JOHNS HOPKINS UNIVERSITY CAPRICOR, INC. JHU Ref: DM – 4562 LICENSE AGREEMENTExclusive License Agreement • March 31st, 2014 • Capricor Therapeutics, Inc. • Pharmaceutical preparations • Maryland
THIS EXCLUSIVE LICENSE AGREEMENT (this “Agreement”) is entered into by and between THE JOHNS HOPKINS UNIVERSITY, a Maryland corporation having an address at 3400 N. Charles Street, Baltimore, MD 21218-2695 (“JHU”) and CAPRICOR, INC., a Delaware corporation having an address at 2415 Old Bosley Road, Lutherville, MD 21093 (“Company”), with respect to the following:
NILE THERAPEUTICS, INC. San Mateo, CA 94402Separation Agreement • March 31st, 2014 • Capricor Therapeutics, Inc. • Pharmaceutical preparations • California
As we have discussed with you, your employment with Nile Therapeutics, Inc. (the "Company") will end effective upon the closing of the transactions contemplated by the Agreement and Plan of Merger and Reorganization dated July 7, 2013, as amended (the "Merger Agreement"), among the Company, Capricor, Inc. and Bovet Merger Corp.
Amended and Restated Technology License AgreementTechnology License Agreement • March 31st, 2014 • Capricor Therapeutics, Inc. • Pharmaceutical preparations • Delaware
Mayo Foundation For Medical Education And Research, a Minnesota charitable corporation, located at 200 First Street SW, Rochester, Minnesota 55905-0001 ("MAYO"); and
